AFP and hepatocellular carcinoma: Further studies by Munson et al. (2023) demonstrated that phagocytosis of HCC-derived AFP altered DC metabolism, decreased expression of co-stimulatory molecules, and increased expression of immune checkpoint molecules such as PD-L1 [32].